scholarly journals Management of Polycystic ovarian syndrome (PCOS) with Ayurveda - a case study

2021 ◽  
Vol 2 (1) ◽  
pp. 133-138
Author(s):  
Dr. Kajal Jha ◽  
Amulya Dahal ◽  
Bijendra Shah ◽  
Pratibha Tripathi ◽  
Sabbu Thasineku ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Teaching Hospital ◽  
Hair Growth ◽  
Polycystic Ovarian Syndrome ◽  
Hormone Level ◽  
Polycystic Ovaries ◽  
Facial Hair ◽  
Common Problems ◽  
Ovarian Syndrome

Polycystic Ovarian Syndrome (PCOS) is one of the most common problems affecting approximately5% of all women.  PCOS can affect menstrual cycle, fertility, and hormone level as well as appearance including acne, facial hair growth and balding, overweight. Some women may suffer from depression. It is also a metabolic problem that affects several body systems. The condition gets its name because there are often an increased number of small painless cysts in the ovaries (polycystic ovaries). It is very difficult to cure in contemporary system and treatment is also very costly. A case of 19 years female suffering from PCOS reported was treated successfully at at Ayurveda Teaching Hospital within 1 month by various ayurveda medicine and panchakarma procedures. The improvement is evident from regularity of menstrual cycle and also from the ultrasonography (USG) reports.

scholarly journals Usefulness of Anti-Müllerian Hormone in Polycystic Ovarian Syndrome in Infertile Women

2019 ◽  
Vol 14 (1) ◽  
pp. 40-43
Author(s):  
Hima Rijal
Keyword(s):  
Menstrual Cycle ◽  
Polycystic Ovarian Syndrome ◽  
Transvaginal Ultrasound ◽  
Clinical Manifestations ◽  
Serum Marker ◽  
Mean Value ◽  
Reproductive Age ◽  
University Teaching ◽  
Polycystic Ovaries ◽  
Ovarian Syndrome

Aims: To correlate the AMH level with various clinical and biochemical parameters in patients presenting to infertility clinic with diagnosis of PCOS. Methods: This is a hospital based prospective study carried out in the Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital from January 2018 to December 2018. Women of reproductive age (21– 35 years) who presented to infertility clinic were recruited for study after taking informed consent. PCOS patients were selected by the Rotterdam criteria. Data regarding menstrual history, clinical manifestations of hyperandrogenism, transvaginal ultrasound (TVS) assessments for ovarian follicles, and the levels of AMH, LH, FSH, testosterone and Estradiol were collected. Blood sampling for hormone measurement (LH, FSH, Testosterone, Estradiol) was performed in the second day of menstrual cycle. Serum AMH was measured in any day of menstrual cycle. TVS was performed for morphology of ovaries during follicular phase. Results: There were 54 patients with PCOS based on Rotterdem criteria. The mean age was 26.6±3.7 year (range=20-35). Among the study population 42 patients (78%) had primary infertility.  High AMH with bilateral polycystic ovaries was in 32(59.2%), bilateral PCO with normal AMH was in 13(24%), unilateral polycystic ovaries with high AMH was in 2(3.7%). AMH mean value was 9.8±4.1 ng/ml (range=2.8-19.8), high in 40 women (74%) and normal in 14 women (26%). Conclusions: Serum AMH can be a useful serum marker of PCOS and it correlates with the clinical and biochemical abnormalities in women with PCOS. Keywords:  anti mullarian hormone, infertility, hyperandrogenism, polycystic ovarian syndrome

scholarly journals AYURVEDIC INTERVENTION IN THE MANAGEMENT OF INFERTILITY ASSOCIATED WITH PCOS, A CASE STUDY

2020 ◽  
pp. 35-36
Author(s):  
S. Srilatha ◽  
Kola Vijaya Kumari
Keyword(s):  
Oral Administration ◽  
Present Article ◽  
Polycystic Ovarian Syndrome ◽  
Polycystic Ovaries ◽  
Marital Conflicts ◽  
Ovarian Syndrome

Infertility is a failure to conceive within one or more years of regular unprotected coitus. ovulatory factor comprises 30-40% of infertility causes, out of this ovulatory factors PCOS is the major one. Polycystic ovarian syndrome is manifested by amenorrhea, hirsutism, and obesity associated with enlarged polycystic ovaries. And this infertility brings marital conflicts, social rejections which may leads to anxiety, disappointments and depression. In Ayurveda, vandyatwa is vatha dosha pradhana vyadi, especially apana vatha which is responsible for all menstrual and ovulatory functions. As the vasthi, the panchakarma procedure is best for vatha vyadis, in this present article a patient of infertility associated with pcos is successfully treated by matravasthi with phala tailam and oral administration of devadrumadi churnam.

Characteristics of Polycystic Ovarian Syndrome in Sub-fertile Woman Attending to GOPD in ShSMCH

2019 ◽  
Vol 11 (1) ◽  
pp. 17-23
Author(s):  
Jinnat Ara Islam ◽  
Fatema Ashraf ◽  
Eva Rani Nandi
Keyword(s):  
Polycystic Ovarian Syndrome ◽  
Polycystic Ovaries ◽  
Cross Sectional ◽  
Medical College ◽  
Appropriate Treatment ◽  
Pcos Group ◽  
Symptom Complex ◽  
Ovarian Syndrome ◽  
Selection Of ◽  
Fertile Women

Background: Polycystic ovarian syndrome (PCOS) is a condition characterized by menstrual abnormalities (oligo/amenorrhea) and clinical or biochemical features of hyperandrogenism and may manifest at any age. It is a common cause of female subfertility. All the dimensions of PCOS have not been yet completely explored. Methods: It was a cross sectional comparative study carried out at-GOPD of Shaheed Suhrawardy Medical College & Hospital from January, 2016 to December 2016 on 162 subfertile women. Among them 54 were PCOS group and 108 were non PCOS group. PCOS was diagnosed by (Rotterdam criteria 2003) (i) Oligo or anovulation (ii) hyperandrogenism (iii) Polycystic ovaries. Study was done to evaluate and compare the demographic characteristics, clinical, biochemical and ultrasoundgraphic features of sub-fertile women with and without PCOS. Results: A total of 162 sub-fertile women aged 16-36 years. Mean age was 29.5±5.4. There were significant differences between the two groups in terms of (oligo/amenorrhea), hirsutism, WHR and ovarian ultrasound features. There were no significant differences between two groups in correlations between the level of obesity with the incidence of anovulation, hyperandrogenism or with hormonal features. Conclusion: PCOS is one of the important factors causing Infertility. It is an ill-defined symptom complex needed due attention. There is a need to increase awareness regarding. The clinical features of PCOS are heterogenous thus can be investigated accordingly of selection of appropriate treatment modality. J Shaheed Suhrawardy Med Coll, June 2019, Vol.11(1); 17-23

scholarly journals An Ayurvedic Approach in Management of Poly Cystic Ovarian Syndrome

2020 ◽  
Vol 11 (4) ◽  
pp. 644-649
Author(s):  
Saroj Kumari ◽  
Sarvesh Kumar Singh ◽  
Kshipra Rajoria ◽  
Avadhesh Kumar
Keyword(s):  
Polycystic Ovarian Syndrome ◽  
Dietary Habits ◽  
Reproductive Age ◽  
Herbal Drugs ◽  
Polycystic Ovaries ◽  
Female Population ◽  
Hormonal Imbalance ◽  
Hormonal Dysfunction ◽  
Cardinal Feature ◽  
Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is a probably fastest growing endocrinological disorder in females of reproductive age. In PCOS, follicular growth is influenced by hormonal imbalance during the ovarian cycle, leads to affected follicles remain in the ovary. The prevalence of PCOS is estimated 6-10% globally and 3.7% - 22.5% in Indian female population, which is relatively high. It is characterised by hyperandrogenism, anovulation and polycystic ovaries which clinically manifests in the terms of amenorrhea or oligomenorrhea, hirsutism, acne, infertility etc. In present scenario, incidence of this disease increasing exponentially due to sedentary lifestyle and faulty dietary habits. This particular disease is not described word to word in Ayurveda. Associated features of PCOS are closely resembling with Bandhya Yonivyapada, Artavavahasrotasa-Vidhha Lakshana, Nastartava and Ksheenaartava described by Acharya Sushruta and Pushpghani Jatharini and Vikuta Jatharini mentioned by Acharya Kashyap. Maximum congruence of PCOS can be established with Bandhya Yonivyapada. The purpose of this study is to understand Nastartava which is the cardinal feature of Bandhya. Word Artava has been used exclusively in Samhita in context of menstrual blood, ovum and ovarian hormones. Therefore Amenorrhea, anovulation, hormonal dysfunction is considered exposed manifestations of Nastartava. Possible line of treatment is stipulated with Nidanaparivarjan, herbal drugs and Panchakarma procedures. Keywords- Ayurveda, Artava, Nastartava, PCOS, Herbal drugs, Panchakarma

scholarly journals Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation

2021 ◽  
Vol 21 (86) ◽  
pp. e200-e205
Author(s):  
Rubina Izhar ◽  
◽  
Samia Husain ◽  
Muhammad Ahmad Tahir ◽  
Mauzma Kausar ◽  
...  
Keyword(s):  
Sensitivity And Specificity ◽  
Ovarian Stimulation ◽  
Ovarian Hyperstimulation Syndrome ◽  
Polycystic Ovarian Syndrome ◽  
Hormone Level ◽  
Antral Follicle ◽  
Antral Follicle Count ◽  
Controlled Ovarian Stimulation ◽  
Ovarian Hyperstimulation ◽  
Ovarian Syndrome

Aim: To compare the rate of ovarian hyperstimulation syndrome in women with and without polycystic ovarian syndrome, and to determine the cut-off for the antral follicle count and the anti-Müllerian hormone level predictive of ovarian hyperstimulation syndrome in both groups. Methods: This was a prospective cohort study conducted in women aged 20–35 years who were undergoing controlled ovarian stimulation. The women were divided into those with polycystic ovarian syndrome and the controls on the basis of the Rotterdam criteria. The outcome of stimulation was recorded, and the ovarian response markers were compared in both groups. Results: Among 689 women included in the study, 276 (40.1%) had polycystic ovarian syndrome, and 476 (59.9%) were used as the controls. Ovarian hyperstimulation syndrome occurred in 19.6% of the cases, and in 7.7% of the controls (p <0.001). The conception rate was greater in the group of cases (52.5% vs. 16.5%, p = 0.001). Among the cases, the sensitivity and specificity for the prediction of hyper-response were 94.4% and 97.3% for AFC, and 92.6% and 93.7% for the anti-Müllerian hormone, at the cut-off values of ≥18 and ≥6.425 ng/ml, respectively. Among the controls, the sensitivity and specificity for the prediction of hyper-response were 93.8% and 97.1% for the antral follicle count, and 93.6% and 94.5% for the anti-Müllerian hormone, at the cut-off values of ≥10 and ≥3.95 ng/ml, respectively. Conclusion: Group-specific values should be used to identify and counsel women undergoing controlled ovarian stimulation. In light of available evidence, gynaecologists should be trained to perform ultrasound evaluation, determine the antral follicle count of their patients, and offer them appropriate counselling.

Wet Cupping and Phlebotomy in Management of Oligo/Amenorrhea: View of Persian Medicine

2020 ◽  
Author(s):  
Azam Meyari ◽  
Fahimeh Ramezani Tehrani ◽  
Mojgan Tansaz ◽  
Roshanak Mokaberinejad ◽  
Mahdi Biglarkhani
Keyword(s):  
Insulin Resistance ◽  
Saphenous Vein ◽  
Polycystic Ovarian Syndrome ◽  
Blood Donation ◽  
Conventional Medicine ◽  
View Point ◽  
Polycystic Ovaries ◽  
Persian Language ◽  
Persian Medicine ◽  
Ovarian Syndrome

Oligo/amenorrhea is one of the most common women’s complaints. The most frequent pathologic causes of this condition is polycystic ovaries that leads to unovulatory cycles. Because of insufficiency of treatment in conventional medicine, we studied view point of Persian Medicine. We searched main Persian Medicine references to collect important information about wet-cupping and phlebotomy in treatment of oligo/amenorrhea especially in patients with Polycystic Ovarian Syndrome. For gathering evidence that establish this idea, we searched main English and Persian language databases for studies about effectiveness of wet-cupping and phlebotomy on menstruation. Excretion blood from lower extremities especially saphenous vein phlebotomy and calves wet-cupping while massive blood excreting is recommended by Persian physicians in Ehtebas-e-tams (oligo/amenorrhea). From the 106 citations identified from electronic searches, at beginning, 3 ones meet our study objectives. These articles showed that wet-cupping effect on menstruation in women with PCOS and fertilization. Although any study didn’t find about effectiveness of phlebotomy on menstruation or fertilization, but majority studies show effect of phlebotomy or blood donation on decrease of insulin resistance. More research about treating this condition needed to confirm the affectiveness of phlebotomy or wet-cupping in treatment of oligo/amenorrhea.

How Common Are Polycystic Ovaries and the Polycystic Ovarian Syndrome in Women With Cushing’s Syndrome?

2001 ◽  
Vol 56 (3) ◽  
pp. 152-153
Author(s):  
G. A. Kaltsas ◽  
M. Korbonits ◽  
A. M. Isidori ◽  
J. A. W. Webb ◽  
P. J. Trainer ◽  
...  
Keyword(s):  
Cushing’S Syndrome ◽  
Polycystic Ovarian Syndrome ◽  
Cushing's Syndrome ◽  
Polycystic Ovaries ◽  
Ovarian Syndrome

scholarly journals POLYCYSTIC OVARIAN SYNDROME;

2013 ◽  
Vol 20 (05) ◽  
pp. 719-725
Author(s):  
SHAZIA SHUKAR-UD-DIN ◽  
SADAF AHMED ASIM ◽  
SYEDA RABIA ◽  
Rumina Tabassum ◽  
Aisha Razzaque
Keyword(s):  
Polycystic Ovarian Syndrome ◽  
Acne Vulgaris ◽  
T Test ◽  
Reproductive Age ◽  
Anthropometric Measurement ◽  
Common Disease ◽  
Polycystic Ovaries ◽  
Serum Lh ◽  
The Mean ◽  
Ovarian Syndrome

Background: Polycystic ovarian syndrome is a common disease among the women in reproductive age group and morecommon in South Asian women. Clinical presentations include menstrual disorders, subfertility, obesity,hirsutism, acne vulgaris andacanthosis. Objectives: The objective of study was to investigate co relation between acne and polycystic ovaries and its relation tomenstrual irregularity. Methodology: A total of 56women were enrolled in the study from Outpatient Department of Obs&Gynae andDermatology, Dow University Hosptial, Ojha campus by convenient sampling. It was cross sectional study, conducted from July 2012 toNovember 2012.Verbal consent was taken. Sociodemographic information,Anthropometric measurement (height, weight, BMI) andacne severity with affected area, menstrual irregularities were administered on pre designed questionnaire.Pelvic ultrasound forpolycystic ovaries and serum LH, FSH in follicular phase of menstrual cycle (2nd day) advised from Dow Radiology and Dow Labrespectively. Results: A total of56 patients of PCOS were enrolled during five month period. The mean age of patient was 21.1+_SD0.994. Frequency of acne was 32 (57.1%).The mean BMI was 19.66 +_SD 4.54. Face was the commonest area involved in 24 (42.9%).menstrual irregularity was found in 50 (89.4%) women. There was no statistically significant relation seen between acne andoligomenorrhea. (X2 = 0.55 , P = 0.45). It was also determined that there was no co relation seen between the acne and serumtestosterone level calculated by independent sample t test.(P = 0.17) but statistically significant association seen between severity ofacne and serum LH/FSH ratio. (t test =3.28, p= 0.004) Conclusion: Acne was found in 32 (57.1%) women with PCOS. The study resultsrevealed a significant association seen between severity of acne and serum LH/FSH ratio. Relation between acne and serum testosteronelevel was statistically insignificant.

scholarly journals Myoinositol In Restoring Spontaneous Ovarian Activity in Patients with Polycystic Ovarian Syndrome (PCOS)

Esculapio ◽  
2020 ◽  
Vol 16 (03, july 2020-Septmber 2020) ◽  
Author(s):  
Ikram u-Allah ◽  
◽  
Nadia Sabeen ◽  
Qaiser Javed Iqbal, ◽  
Shazia Zulfiqar, ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Random Sampling ◽  
Ovulation Induction ◽  
Polycystic Ovarian Syndrome ◽  
Ovarian Activity ◽  
Menstrual Irregularity ◽  
Medical Sciences ◽  
Quasi Experimental ◽  
The Mean ◽  
Ovarian Syndrome

Objective: To assess the efficacy of myoinositol in the management of patients with Polycystic ovarian syndrome (PCOS) Methods: It was quasi experimental study conducted inDepartment of Obstetrics and Gynecology Services institute of Medical Sciences, Services Hospital, Lahore from 30-6-2018 to 31-12-2018. 140 sub fertile patients with PCOS were selected through random sampling. Patients were given 2gram of myoinositol/day. The effect was assessed after 3 and 6 months of treatment by monthly menstrual cycle regularity and ovulation. All this information was recorded in proforma. Results: The mean age of patients was 26.90±5.52years. The mean BMI of patients was 37.38±4.08kg/m2. After 3 months of treatment, menstrual cycle become regular in 34 (24.3%) patients and ovulation occurred in 54 (38.6%) cases. After 6 months of treatment, menstrual cycle become regular in 75 (53.6%) patients and ovulation occurred in 101 (72.1%) cases. Conclusion: The myoinositol is an effective treatment in terms of regularity of menstrual cycle and ovulation induction in subfertile women with PCOS. Keywords: Myoinositol, Polycystic ovarian syndrome, Menstrual irregularity, Ovulation

Sign in / Sign up

Export Citation Format

Share Document